Login Register Cart 0
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

COVID-19: Small-Molecule Clinical Trials Landscape

Author(s): Leonardo L.G. Ferreira and Adriano D. Andricopulo*

Volume 20, Issue 18, 2020

Page: [1577 - 1580] Pages: 4

DOI: 10.2174/156802662018200703154334

Next »
[1]
World Health Organization. Novel Coronavirus – China. Available from:. https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/ (Accessed June 23, 2020).
[2]
World Health Organization. Coronavirus disease (COVID-19) pandemic. Available from:. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (Accessed June 23, 2020).
[3]
U.S. National Library of Medicine. ClinicalTrials.gov. Available from:. https://clinicaltrials.gov/ (Accessed June 23, 2020).
[4]
European Medicines Agency. EU Clinical Trials Register. Available from:. https://www.clinicaltrialsregister.eu/ (Accessed June 23, 2020)
[5]
BioMed Central Ltd. ISRCTN registry. Available from:. https://www.isrctn.com/page/about (Accessed June 23, 2020).
[6]
Chinese Clinical Trial Registry. ChiCTR. Available from:. http://www.chictr.org.cn/enindex.aspx (Accessed June 23, 2020).
[7]
Ferreira, L.G.; Andricopulo, A.D. Drug repositioning approaches to parasitic diseases: a medicinal chemistry perspective. Drug Discov. Today, 2016, 21, 1699-1710.
[8]
Armando, R.G.; Mengual Gómez, D.L.; Gomez, D.E. New drugs are not enough‑drug repositioning in oncology: An update. Int. J. Oncol., 2020, 56, 651-684.
[9]
Kloner, R.; Padma-Nathan, H. Erectile dysfunction in patients with coronary artery disease. Int. J. Impot. Res., 2005, 17, 209-215.
[10]
Lu, D.Y.; Wu, H.Y.; Yarla, N.S.; Xu, B.; Ding, J.; Lu, T.R. HAART in HIV/AIDS Treatments: Future Trends. Infect. Disord. Drug Targets, 2018, 18, 15-22.
[11]
World Health Organization. Draft landscape of COVID-19 candidate vaccines. Available from:. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines (Accessed June 17, 2020).
[12]
Warren, T.K.; Jordan, R.; Lo, M.K.; Ray, A.S.; Mackman, R.L.; Soloveva, V.; Siegel, D.; Perron, M.; Bannister, R.; Hui, H.C.; Larson, N.; Strickley, R.; Wells, J.; Stuthman, K.S.; Van Tongeren, S.A.; Garza, N.L.; Donnelly, G.; Shurtleff, A.C.; Retterer, C.J.; Gharaibeh, D.; Zamani, R.; Kenny, T.; Eaton, B.P.; Grimes, E.; Welch, L.S.; Gomba, L.; Wilhelmsen, C.L.; Nichols, D.K.; Nuss, J.E.; Nagle, E.R.; Kugelman, J.R.; Palacios, G.; Doerffler, E.; Neville, S.; Carra, E.; Clarke, M.O.; Zhang, L.; Lew, W.; Ross, B.; Wang, Q.; Chun, K.; Wolfe, L.; Babusis, D.; Park, Y.; Stray, K.M.; Trancheva, I.; Feng, J.Y.; Barauskas, O.; Xu, Y.; Wong, P.; Braun, M.R.; Flint, M.; McMullan, L.K.; Chen, S.S.; Fearns, R.; Swaminathan, S.; Mayers, D.L.; Spiropoulou, C.F.; Lee, W.A.; Nichol, S.T.; Cihlar, T.; Bavari, S. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature, 2016, 531, 381-385.
[13]
Sheahan, T.P.; Sims, A.C.; Graham, R.L.; Menachery, V.D.; Gralinski, L.E.; Case, J.B.; Leist, S.R.; Pyrc, K.; Feng, J.Y.; Trantcheva, I.; Bannister, R.; Park, Y.; Babusis, D.; Clarke, M.O.; Mackman, R.L.; Spahn, J.E.; Palmiotti, C.A.; Siegel, D.; Ray, A.S.; Cihlar, T.; Jordan, R.; Denison, M.R.; Baric, R.S. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci. Transl. Med., 2017, 9, eaal3653.
[14]
Gordon, C.J.; Tchesnokov, E.P.; Woolner, E.; Perry, J.K.; Feng, J.Y.; Porter, D.P.; Götte, M. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. J. Biol. Chem., 2020, 295, 6785-6797.
[15]
Sheahan, T.P.; Sims, A.C.; Zhou, S.; Graham, R.L.; Pruijssers, A.J.; Agostini, M.L.; Leist, S.R.; Schäfer, A.; Dinnon, K.H., III; Stevens, L.J.; Chappell, J.D.; Lu, X.; Hughes, T.M.; George, A.S.; Hill, C.S.; Montgomery, S.A.; Brown, A.J.; Bluemling, G.R.; Natchus, M.G.; Saindane, M.; Kolykhalov, A.A.; Painter, G.; Harcourt, J.; Tamin, A.; Thornburg, N.J.; Swanstrom, R.; Denison, M.R.; Baric, R.S. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci. Transl. Med., 2020, 12, eabb5883.

Rights & Permissions Print Cite
Article Metrics
117
4
1
World Chagas Disease
© 2024 Bentham Science Publishers | Privacy Policy